ArticleArchives of dermatological research2025
Role of immune cells in seborrheic dermatitis: a two-sample bidirectional Mendelian randomization study.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prior research has indicated a link between seborrheic dermatitis (SD) and dysregulated immune responses; however, the causal linkage between this association and certain immune cell features has yet to be thoroughly clarified. This study seeks to examine the potential causal influence of immune cell characteristics on the pathogenesis of seborrheic dermatitis (SD) and to evaluate if these characteristics can function as biomarkers for early diagnosis and therapy. Data mining was performed using the Genome-Wide Association Study (GWAS) Catalog database to select 731 immune cell features for exposure variables and seborrheic dermatitis for the outcome variable in a forward Mendelian Randomization (MR) study. In a reverse MR analysis, seborrheic dermatitis was designated as the exposure factor, while the significant immune cell traits recognized by a forward MR analysis were used as outcome factors to exclude potential reverse causality. Five MR analyses were carried out by utilizing methods such as inverse variance weighting (IVW). Additionally, false discovery rate (FDR) correction, heterogeneity testing, level-dependent pleiotropy analysis, and sensitivity analysis were conducted. This study identified 11 immune traits causally associated with seborrheic dermatitis (SD). Specifically, five immune phenotypes were found to have been linking to a lower risk of SD: CD24on transitional, CD28 - DN(CD4 - CD8-)%T cell, CD45RA - CD28 - CD8br AC, Resting Treg%CD4, SSC - A on NKT. Conversely, six immunized traits have been shown with a greater risk of SD: CD127 - CD8br AC, CD20on CD24 + CD27+, CD27on IgD - CD38br, CD27on unsw mem, CD28 + DN(CD4 - CD8-)%T cell, HLA DR on CD33br HLA DR + CD14dim. The sensitivity analysis showed an absence of heterogeneity and level-dependent pleiotropy.This study demonstrates that specific immune cell traits not only correlate with SD but also provide valuable mechanistic insights into its pathogenesis. These immune traits also hold promise as biomarkers for early diagnosis, risk stratification, and personalized therapy. In addition, the findings provide new insights into immune mechanisms, highlighting the potential of targeted immunotherapies in SD treatment.
Indexed as
Identifiers
39994123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.